Combination of LABA + inhaled glucocorticoid safe in asthma

Combination of LABA + inhaled glucocorticoid safe in asthma
(HealthDay)—Compared to treatment with an inhaled glucocorticoid alone, combination therapy with a long-acting β2-agonist (LABA) and an inhaled glucocorticoid is not associated with a significantly higher risk of serious asthma-related events, according to a study published online June 27 in the New England Journal of Medicine.

William W. Busse, M.D., from the University of Wisconsin School of Medicine and Public Health in Madison, and colleagues performed a combined analysis of four trials comparing an inhaled glucocorticoid plus a LABA with an inhaled glucocorticoid alone in adolescents and adults with asthma.

The researchers identified three asthma-related intubations (two in the inhaled-glucocorticoid , one in the group) and two asthma-related deaths (both in the combination- group) in four patients among the 36,010 patients in the intention-to-treat study. In a secondary analysis of serious asthma-related events, 0.6 percent of 18,006 patients in the inhaled-glucocorticoid group and 0.66 percent of 18,004 in the combination-therapy group had at last one composite event (relative risk in the combination therapy group, 1.09; 95 percent confidence interval, 0.83 to 1.43; P = 0.55); 11.7 and 9.8 percent, respectively, had at least one asthma exacerbation (relative risk, 0.83; 95 percent confidence interval, 0.78 to 0.89; P < 0.001).

"Combination therapy with a LABA plus an inhaled glucocorticoid did not result in a significantly higher risk of serious asthma-related events than treatment with an inhaled glucocorticoid alone but resulted in significantly fewer asthma exacerbations," the authors write.

Several authors disclosed ties to the pharmaceutical and medical device industries.


Explore further

Study shows combination drug therapy for asthma patients is safe

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: New England Journal of Medicine

Copyright © 2018 HealthDay. All rights reserved.

Citation: Combination of LABA + inhaled glucocorticoid safe in asthma (2018, June 28) retrieved 20 May 2019 from https://medicalxpress.com/news/2018-06-combination-laba-inhaled-glucocorticoid-safe.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more